相关实验视频
Updated: Jun 12, 2026

Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
后生物:癌症治疗中的新兴生物活性剂
Sihan Li1, Fashun Li1, Jiasheng Tu1
1NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients and Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.
后生物质,益生菌的有益副产品,通过增强治疗和调节免疫反应,在癌症治疗中表现有前途. 临床使用需要标准化.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 后生物质是益生菌的功能继承者,保留了关键的生物活性特性.
- 它们调解宿主-微生物相互作用,并影响瘤生物学和免疫调节.
- 后生物质药物有潜力增强抗癌治疗,并提高安全性.
研究的目的:
- 系统地根据它们的形成对后生物进行分类.
- 为了阐明后生菌抗瘤活性的机制.
- 解决阻碍临床应用的挑战,并指导未来的开发.
主要方法:
- 文献综述和综合关于后生物学的当前研究.
- 对后生物形成过程和作用机制的分析.
- 评估治疗潜力和临床挑战.
主要成果:
- 后生物体在调节瘤扩散,转移和免疫反应方面具有显著的潜力.
- 它们可以与现有的抗癌疗法协同作用.
- 目前的局限性包括不准确的定义和缺乏标准化的制造.
结论:
- 基于后生物的癌症治疗是一个不断发展的领域,具有显著的治疗前景.
- 系统的分类和标准化对于临床翻译至关重要.
- 需要进一步的研究和工业开发来克服当前的挑战.
更多相关视频
06:07Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
11:003D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
Published on: October 17, 2025
相关概念视频
Drugs that Stabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics
Probiotics